Fellow posters
Often when the wonderful story of Cardiocell patches is mentioned in company reports there is also the reference to "franchise". For example in Chairman Catlow's report in the 11/12 Annual Report he has a sub-heading "Regenerative Medicine Franchise".
What exactly does this mean? Are we paying a licence fee to the owners of the technology (people or corporate)? Does anybody know? What is the history and how many dollars per patch do we have to pay?
I would like to have a full understanding ... not saying that there is anything wrong ...
Cheers
patch sales when we are a franchise
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |